Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) (Q82672660)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 February 2006

Language	Label	Description	Also known as
English	Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer)	scientific article published on 28 February 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Philippe Morice

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

J M Classe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

P Rauch

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J F Rodier

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

E Stoeckle

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Lasry

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

G Houvenaeghel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Groupe des Chirurgiens de Centre de Lutte Contre le Cancer

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

28 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

102

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

523-529

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Epidemiology of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Update on the treatment of cervical and uterine carcinoma: focus on topotecan

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

New gynecologic cancer staging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Modern management of locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

A glossary for reporting complications of treatment in gynecological cancers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Complications of uterine cervix carcinoma treatments: the problem of a uniform classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Radical surgery after induction chemotherapy in locally advanced cervical cancer. A feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer--therapeutic advance or surgical folly?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Class II versus Class III Radical Hysterectomy in Stage IB–IIA Cervical Cancer: A Prospective Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Treatment of stage IB2 (bulky) cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.022

7 January 2021

Identifiers

10.1016/J.YGYNO.2006.01.022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16504274%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82672660&oldid=2043356419"